文献速递肿瘤 PET/CT核素与放射性配体治疗

艾日布林通过18F-DiFA PET显像改善肿瘤氧合增强放疗敏感性

Eribulin improves tumor oxygenation demonstrated by 18F-DiFA hypoxia imaging, leading to radio-sensitization in human cancer xenograft models.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2021-09-01

该研究利用新型缺氧PET探针18F-DiFA,在乳腺癌MDA-MB-231和肺癌NCI-H1975小鼠移植瘤模型中评估艾日布林对肿瘤氧合的影响及其对放疗敏感性的作用。结果显示艾日布林剂量依赖性降低18F-DiFA积聚,治疗7天后最显著,并减少哌莫硝唑阳性缺氧区域;联合放疗较对照组、单放疗组和单药组显著延缓肿瘤生长,且放疗后肿瘤生长与18F-DiFA积聚呈负相关。

要点

  • 艾日布林剂量依赖性改善肿瘤氧合,18F-DiFA PET可无创监测。
  • 艾日布林联合放疗较单放疗或单药显著抑制肿瘤生长。
  • 放疗后肿瘤生长与18F-DiFA积聚负相关,提示氧合改善预测放疗反应。

核心结论

  • 18F-DiFA PET/CT可清晰检测艾日布林诱导的肿瘤氧合改善。
  • 艾日布林通过改善肿瘤氧合有效增强放疗的抗肿瘤活性。

研究设计与样本

  • 研究采用人乳腺癌MDA-MB-231和人肺癌NCI-H1975细胞小鼠移植瘤模型。
  • 小鼠单次给予艾日布林后注射18F-DiFA和哌莫硝唑分析肿瘤缺氧区域。
  • 联合放疗组在局部X线照射前进行18F-DiFA PET/CT显像,照射后隔日测量肿瘤大小。

主要发现

  • 艾日布林剂量依赖性显著降低18F-DiFA积聚水平。
  • 艾日布林治疗后7天18F-DiFA积聚降低最显著。
  • 哌莫硝唑阳性缺氧区域减少支持上述结果。
  • 联合治疗较对照、单放疗和单药组显著延缓肿瘤生长。
  • 放疗后肿瘤生长与18F-DiFA积聚呈负相关。

临床怎么用

  • 18F-DiFA PET/CT可用于监测艾日布林治疗后的肿瘤氧合变化。
  • 艾日布林联合放疗可能提高放疗疗效,尤其适用于氧合改善的肿瘤。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Eribulin, an inhibitor of microtubule dynamics, is known to show antitumor effects through its remodeling activity in the tumor vasculature. However, the extent to which the improvement of tumor hypoxia by eribulin affects radio-sensitivity remains unclear. We utilized 1-(2,2-dihydroxymethyl-3-18F-fluoropropyl)-2-nitroimidazole (18F-DiFA), a new PET probe for hypoxia, to investigate the effects of eribulin on tumor hypoxia and evaluate the radio-sensitivity during eribulin treatment. METHODS: Mice bearing human breast cancer MDA-MB-231 cells or human lung cancer NCI-H1975 cells were administered a single dose of eribulin. After administration, mice were injected with 18F-DiFA and pimonidazole, and tumor hypoxia regions were analyzed. For the group that received combined treatment with radiation, 18F-DiFA PET/CT imaging was performed before tumors were locally X-irradiated. Tumor size was measured every other day after irradiation. RESULTS: Eribulin significantly reduced 18F-DiFA accumulation levels in a dose-dependent manner. Furthermore, the reduction in 18F-DiFA accumulation levels by eribulin was most significant 7 days after treatment. These results were also supported by reduction of the pimonidazole-positive hypoxic region. The combined treatment showed significant retardation of tumor growth in comparison with the control, radiation-alone, and drug-alone groups. Importantly, tumor growth after irradiation was inversely correlated with 18F-DiFA accumulation. CONCLUSION: These results demonstrated that 18F-DiFA PET/CT clearly detected eribulin-induced tumor oxygenation and that eribulin efficiently enhanced the antitumor activity of radiation by improving tumor oxygenation.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Bo T, Yasui H, Shiga T, et al. Eribulin improves tumor oxygenation demonstrated by 18F-DiFA hypoxia imaging, leading to radio-sensitization in human cancer xenograft models. Eur J Nucl Med Mol Imaging. 2021. PMID: 34468781. doi:10.1007/s00259-021-05544-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。